Mark E. Mapstone, Ph.D.
Affiliations: | 2000 | Northwestern University, Evanston, IL |
Area:
Aging; Alzheimer's Disease; Aphasia; Dementia; Frontotemporal Dementia; Memory Disorders; Memory Disorders of Aging; Neuropsychology; Primary Progressive AphasiaGoogle:
"Mark Mapstone"Mean distance: 17.69 (cluster 14) | S | N | B | C | P |
Parents
Sign in to add mentor| Sandra Weintraub | grad student | 2000 | Northwestern | |
| (Selective attention following unilateral cerebral lesions: Evidence for deficits in global distribution of attention.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gorijala P, Aslam MM, Dang LT, et al. (2023) Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndrome. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Gasca-Salas C, Duff-Canning S, McArthur E, et al. (2023) Predictors of Cognitive Change in Parkinson Disease: A 2-year Follow-up Study. Alzheimer Disease and Associated Disorders |
| Stern AM, Van Pelt KL, Liu L, et al. (2023) Plasma NT1-tau and Aβ correlate with age and cognitive function in two large Down syndrome cohorts. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Stern AM, Van Pelt KL, Liu L, et al. (2023) Plasma NT1-tau and Aβ correlate with age and cognitive function in two large Down syndrome cohorts. Medrxiv : the Preprint Server For Health Sciences |
| O'Bryant SE, Zhang F, Petersen M, et al. (2021) A blood screening tool for detecting mild cognitive impairment and Alzheimer's disease among community-dwelling Mexican Americans and non-Hispanic Whites: A method for increasing representation of diverse populations in clinical research. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Petersen ME, Rafii MS, Zhang F, et al. (2020) Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome. Journal of Alzheimer's Disease : Jad |
| Yilmaz A, Ustun I, Ugur Z, et al. (2020) A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning. Journal of Alzheimer's Disease : Jad |
| Chen Q, Baran TM, Rooks B, et al. (2020) Cognitively supernormal older adults maintain a unique structural connectome that is resistant to Alzheimer's pathology. Neuroimage. Clinical. 28: 102413 |
| Handen BL, Lott IT, Christian BT, et al. (2020) The Alzheimer's Biomarker Consortium-Down Syndrome: Rationale and methodology. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12065 |
| Petersen ME, Zhang F, Schupf N, et al. (2020) Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS) study. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12039 |